• MAPK10-Mediated KRT16 Degradation Suppresses NSCLC Metastasi

  2026-07-29

  This study uncovers a phosphorylation-dependent mechanism by which MAPK10 suppresses non-small cell lung cancer (NSCLC) metastasis through targeted degradation of keratin 16. The findings establish the MAPK10/KRT16/RNF213 axis as a potential prognostic biomarker and therapeutic target, with implications for personalized cancer treatment strategies.

• Phytol-Driven RXR Activation: Workflows, Troubleshooting, an

  2026-07-29

  Phytol (trans-Phytol) excels as a robust RXR activator and molecular probe, bridging nuclear hormone receptor research with advanced materials assembly. This article delivers actionable protocols, troubleshooting strategies, and comparative insights to help researchers harness Phytol’s unique solubility and signaling profile for reproducible, high-impact results.

• Necrostatin-1: RIP1 Kinase Inhibition in Translational Resea

  2026-07-28

  This thought-leadership article delivers mechanistic depth and actionable guidance for translational researchers leveraging Necrostatin-1 (Nec-1) as a selective RIP1 kinase inhibitor. Bridging rigorous protocol insight with strategic outlook, it explores necroptosis assay design, translational relevance in tissue injury and inflammation, and how APExBIO’s Necrostatin-1 uniquely empowers reproducible and impactful discovery. The piece differentiates itself by integrating evidence from new domains, such as recent advances in regulated cell death, and by referencing both product intelligence and recent literature.

• N3-kethoxal: Elevating RNA and DNA Structure Mapping in Tran

  2026-07-28

  This thought-leadership article explores the mechanistic utility and translational impact of N3-kethoxal, an advanced membrane-permeable nucleic acid probe from APExBIO. Focusing on its innovative chemistry, the article integrates recent literature—especially the CasKAS ssDNA mapping approach—to provide strategic guidance for researchers seeking sensitive, scalable, and clinically relevant solutions for RNA secondary structure probing and genomic mapping of accessible DNA. The discussion advances beyond standard product summaries by unifying evidence, workflow insights, and future-facing perspectives on precision nucleic acid profiling.

• Resazurin Sodium Salt in Precision Toxicity Profiling: Mecha

  2026-07-27

  Explore how Resazurin sodium salt, a fluorogenic oxidation-reduction indicator, enables advanced, quantitative toxicity profiling and viability analysis—unveiling mechanistic nuances and assay optimization strategies that go beyond standard cell biology workflows.

• Temozolomide: Mechanistic Benchmarks for DNA Repair Studies

  2026-07-27

  Temozolomide is a small-molecule alkylating agent that induces DNA damage by methylating guanine bases, enabling precise DNA repair mechanism research. It is widely used in glioma and cancer model systems, with validated benchmarks for solubility and cytotoxicity. Combinatorial use with kinase inhibitors reveals heightened efficacy in ATRX-deficient glioma models.

• Rucaparib (AG-014699): Redefining PARP Inhibition in Precisi

  2026-07-26

  Explore the advanced scientific mechanisms of Rucaparib (AG-014699) as a potent PARP inhibitor, emphasizing its impact on DNA repair and radiosensitization in cancer research. This article provides a fresh, in-depth analysis of recent spliceosome acetylation findings, offering researchers unique insights and practical guidance.

• Apoptotic Priming in Glioblastoma: Targeting BCL-XL and MCL-

  2026-07-25

  This article analyzes a recent study revealing that glioblastoma cells, especially stem-like subpopulations, display heightened apoptotic priming due to elevated expression of anti-apoptotic BCL-XL and MCL-1. The findings highlight the therapeutic potential of sequential BCL-XL and MCL-1 inhibition with BH3-mimetics for overcoming treatment resistance in glioblastoma.

• Leupeptin Hemisulfate Salt: Workflow Precision in Protease R

  2026-07-24

  Leupeptin hemisulfate salt empowers researchers with high-specificity, reversible inhibition of key serine and cysteine proteases, crucial for precise control in protein degradation and viral replication assays. This guide details experimental workflows, advanced applications, and troubleshooting strategies to maximize reliability in protease activity regulation studies.

• Sumatriptan’s Emerging Anti-Inflammatory Role: Systematic Re

  2026-07-24

  Ala et al. systematically reviewed evidence that sumatriptan, beyond its established use in migraine, exhibits reproducible anti-inflammatory effects across diverse experimental models. Their findings suggest sumatriptan modulates inflammatory mediators and signaling pathways, with potential implications for translational therapeutics outside neurology.

• Moxifloxacin in Research: Protocols and Advanced Use-Cases

  2026-07-23

  Moxifloxacin, a potent fluoroquinolone antibiotic, is revolutionizing cellular and metabolic research with reproducible, dose-dependent effects. This guide details experimental workflows, troubleshooting, and the unique advantages of APExBIO's Moxifloxacin for antibiotic toxicity and metabolic pathway studies.

• L-Threonine (SKU C6127): Reliable Optimization for Cell Assa

  2026-07-23

  This authoritative review addresses core laboratory challenges in cell viability and metabolic profiling, demonstrating how L-Threonine (SKU C6127) from APExBIO ensures reproducible, sensitive results across workflows. Integrating scenario-based Q&As, the article delivers practical strategies and evidence-driven solutions for biomedical researchers and technicians seeking validated amino acid supplementation.

• NF-κB/miR-202-5p/HMGB2 Feedback in Septic AKI Attenuation

  2026-07-22

  This study uncovers a negative feedback loop involving NF-κB, miR-202-5p, and HMGB2 that mitigates inflammation and cell death in sepsis-induced acute kidney injury (AKI). By elucidating how NF-κB-driven miR-202-5p induction targets HMGB2 and suppresses pathological inflammation, the research provides new mechanistic insight and therapeutic avenues for septic AKI.

• Metformin Hydrochloride in Fibrosis and Metabolic Research W

  2026-07-22

  Metformin Hydrochloride (Metformin HCl) offers unique advantages for dissecting fibrosis and metabolic signaling, especially through AMPK pathway modulation. This article translates recent breakthroughs—such as the attenuation of vocal fold fibrosis—into robust, reproducible protocols, troubleshooting guidance, and comparative insights for advanced metabolic research.

• Gamma-Linolenic Acid: Translational Leverage in Inflammation

  2026-07-21

  This thought-leadership article dissects the mechanistic and translational edge of gamma-linolenic acid (GLA) in anti-inflammatory research. It bridges molecular mechanisms with experimental strategy and clinical relevance, offering concrete guidance to translational researchers seeking robust, reproducible, and clinically-aligned approaches. By critically referencing recent antibacterial stewardship findings and integrating workflow recommendations, the article positions GLA, as supplied by APExBIO, at the forefront of next-generation inflammation research.

456 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page